Article

1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes.

Interdepartmental Nutrition Program, Purdue University, West Lafayette, IN 47907, USA.
The Journal of Steroid Biochemistry and Molecular Biology (Impact Factor: 4.05). 10/2008; 112(1-3):122-6. DOI: 10.1016/j.jsbmb.2008.09.006
Source: PubMed

ABSTRACT High vitamin D intake is associated with reduced insulin resistance. Expression of extra-renal 1alpha,25-dihydroxyvitamin D hydroxylase (1alpha-hydroxylase) has been reported in several tissues and contributes to local synthesis of 1alpha,25-dihydroxyvitamin D(3) (1,25(OH)(2)D) from the substrate 25-hydroxyvitamin D (25OHD). Expression and dietary regulation of 1alpha-hydroxylase in tissues associated with energy metabolism, including adipose tissue, has not been assessed. Male Wistar rats were fed a high calcium (1.5%) and high vitamin D (10,000IU/kg) or a low calcium (0.25%), low vitamin D (400IU/kg) with either a high fat (40% energy) or high sucrose (66% energy) dietary background for 14 weeks. Expression of 1alpha-hydroxylase, assessed by real time PCR, was detected in adipose tissue and did not differ with dietary level of calcium and vitamin D. 1alpha-Hydroxylase mRNA was also detected in 3T3-L1 preadipocytes and 25OHD treatment at 10nM levels induced 1,25(OH)(2)D responsive gene, CYP24, and this response was reduced in the presence of the p450 inhibitor, ketoconazole. In addition, (3)H 25OHD was converted to (3)H 1,25(OH)(2)D in intact 3T3-L1 preadipocytes. Cumulatively, these results demonstrate that 1alpha-hydroxylase is expressed in adipose tissue and is functional in cultured adipocytes. Thus, the capacity for local production may play a role in regulating adipocyte growth and metabolism.

Download full-text

Full-text

Available from: Yan Jiang, Jun 16, 2015
0 Followers
 · 
105 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vitamin D (VD) displays immunoregulatory effects and reduces adipocyte inflammation, which may participate to a reduction of adipose tissue macrophage infiltration in the context of obesity-associated low-grade inflammation. These observations have been described mainly in vitro, through the evaluation of a limited number of inflammatory markers. Here, we studied the effects of 1,25 dihydroxy-vitamin D on chemokine network expression in adipocytes (by transcriptomic approach) and we confirm the physiological relevance of these data in vivo, by demonstrating the effect of vitamin D on cytokine and chemokine gene expression as well as on macrophage infiltration in adipose tissue. 1,25(OH)2D down-regulated (-1.3- to -10.8-fold) the mRNA expression of 29 chemokines and limited macrophage migration in TNFα-conditioned adipocyte medium (1.5-fold; p<0.05). This effect was associated with a reduction in p65 and IκB phosphorylation (2-fold compared with TNFα; p<0.05). The effects of VD were confirmed in mice injected intraperitoneally with LPS (acute inflammation) and diet-induced obese mice (metabolic inflammation), where the levels of mRNA encoding proinflammatory cytokines and chemokines (approximately 2-fold) were reduced in adipocytes (acute and metabolic inflammation) and adipose tissue and that macrophage infiltration was also inhibited in the adipose tissue of obese mice (metabolic inflammation). Altogether, these results showed that VD displayed a global immonuregulatory impact on adipocytes, notably via the inhibition of chemokine expression and macrophage infiltration in inflamed adipose tissue.
    Endocrinology 03/2015; 156(5):en20141647. DOI:10.1210/en.2014-1647 · 4.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vitamin D is a nutrient with emerging roles in cardiovascular, immune, and musculoskeletal function. Vitamin D (VITD) levels are inversely correlated with weight status in adults. This study was designed to determine the prevalence of vitamin D deficiency and insufficiency in a retrospective sample of overweight or obese Soldiers who had attended weight management classes at Fort Bliss, Texas. The study design was a cross-sectional, retrospective review of electronic outpatient medical records of 314 active duty Soldiers. The mean age of the Soldiers was 31, mean body mass index was 32, and 69% were classified as obese. Twenty-one percent of Soldiers were classified VITD-deficient based on having serum 25-hydroxy VITD concentrations < 20 ng/mL, and 51% were classified as insufficient (20-29 ng/mL). In a multivariate logistic regression model, non-Hispanic Black and Hispanic race were significant predictors of both VITD deficiency and insufficiency. The high rate of vitamin D deficiency and insufficiency in this sample of Soldiers is concerning. Given the important roles of VITD in the body, it is imperative that further study of both normal and overweight Soldiers be conducted in order to determine prevalence. Reprint & Copyright © 2015 Association of Military Surgeons of the U.S.
    Military medicine 02/2015; 180(2):237-40. DOI:10.7205/MILMED-D-14-00041 · 0.77 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To date the published data concerning the possible interplay between vitamin D (VitD) and Vit D receptor (VDR) gene polymorphism with the immune/inflammatory mediators in type 2 diabetes mellitus (DM) is insufficient. Some of the immune non-classical actions of vitamin D may point to its role in the pathogenesis of type 2 DM through down-regulation of cytokines (IL-6). Although there is evidence to support a relationship among vitamin D status, chronic inflammation and insulin resistance, the underlying mechanism requires further exploration. We aimed to investigate the role of vitamin D in chronic inflammation and insulin resistance in type 2 DM. Moreover, to examine the association of VDR gene polymorphisms [VDR 2228570 C > T (FokI); VDR 1544410 A > G (BsmI)] with the components of metabolic syndrome (MetSyn) in type 2 diabetic Egyptian patients .
    12/2014; 2:540-556. DOI:10.1016/j.mgene.2014.07.002